🎥 A Biotech(!) With More Reward and Less Risk

There's a lot to like...‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Note: Is stevenmagallanes520.nims@blogger.com your correct email? You haven't clicked in a while and we're concerned you might lose access. Please confirm your address with one click here. Stocks Gold Crypto Trading Academy Stock of the Week: More Reward, Less Risk With This Healthy Biotech SPONSORED Forget About Any of the Other Metrics - THIS Is the Only Thing You NEED TO KNOW Before Buying a Crypto Cryptos don't move because they've inked a big partnership... solved some economic problem... or even promised to change the world. The reason they move is they've experienced something we call "the Armstrong Effect," a lucrative phenomenon that's appeared before many of the biggest crypto runs. It even showed up before a 27,865% gain in two days! Click here for a live demo of its lucrative profit potential... Alpesh Patel Trading Champion One of the things that I love about investing is it helps me learn so much about the world. When I analyze stocks, I get a new understanding of how the world's moving and what companies are doing to solve some of the biggest global problems... and I learn about the innovative, amazing technologies they're using. That's why I'm so excited about this week's Stock of the Week. [Could "XRI" spark the biggest investment boom since the internet? Find Out Here.] It's a biotech company looking to solve some of the world's biggest medical problems... including chronic conditions, cardiovascular and infectious diseases, and cancer. The stock has strong momentum... low volatility... and an outstanding Sortino ratio. That means it has a great risk-reward profile. There's a lot to like... and I get into it all in my latest video. Click here or on the image below to watch it. SEE THE STOCK HERE Happy hunting, Alpesh Editor's Note: Want another free pick? Andy's giving away the name of a completely new type of investment... one that's outside the volatile stock and crypto markets. Get the details here. SPONSORED The Forever Battery: Making Gas Guzzlers Obsolete Only 2% of cars sold in the U.S. today are electric vehicles… but that's about to change - FAST. A new battery breakthrough is ready to hit the market. It could revolutionize the $2 trillion automotive industry... and could soon make gas guzzlers obsolete. This technology is predicted to cause a 1,500% surge in electric vehicle sales over the next four years. The company pioneering this new battery could be the investment of a lifetime. Click here for details.   Want more content like this? YES NO   Alpesh Patel | Trading Champion Alpesh Patel is an award-winning hedge fund and private equity fund manager, international bestselling author, and entrepreneur. He is the founder and CEO of Praefinium Partners, a Financial Times top FTSE 100 forecaster, and a senior Dealmaker in the U.K.'s Department for International Trade. As a recognized authority on fintech, online trading and venture capital, his past and current client list includes American Express, Merrill Lynch HSBC, Charles Schwab, Goldman Sachs, Barclays... and more.   Was this email forwarded to you? Click here to sign up! You are receiving this email because you subscribed to Manward Financial Digest. To unsubscribe from Manward Financial Digest, click here. Need help with your account? Click here. Have a question or comment for the editor? Click here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Manward Press, LLC | Attn: Support Team | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.682.5210 | International: +1.443.353.4263 Website | Privacy Policy Keep the emails you value from falling into your spam folder. Whitelist Manward Financial Digest. © 2021 Manward Press, LLC | All Rights Reserved Manward Press, LLC is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that investment markets have inherent risks and there can be no guarantee of future profits. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by Manward Press, LLC should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Manward Press, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.